PR Newswire - CARsgen Announces Data of Allogeneic BCMA CAR-T Ce...
SHANGHAI, Dec. 8, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announced that clinical data...
Read More

ภาษาไทย
English